We are live on ! Find out more
SGHT icon

Sight Sciences

65 hedge funds and large institutions have $87.6M invested in Sight Sciences in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $177K | Put options by funds: $164K

0% more capital invested

Capital invested by funds: $87.2M → $87.6M (+$377K)

0% more funds holding

Funds holding: 6565 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

1.22% less ownership

Funds ownership: 34.66%33.44% (-1.2%)

13% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 23

Holders
65
Holders Change
Holders Change %
0%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
20
Reduced
23
Closed
12
Calls
$177K
Puts
$164K
Net Calls
+$13K
Net Calls Change
+$67K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
1
Bank of America
North Carolina
$16.7M -$55.2K -11,731 -0.4%
UBS Group
2
UBS Group
Switzerland
$15.2M -$114K -24,194 -0.8%
JSP
3
Jackson Square Partners
California
$8.5M -$93.2K -19,824 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$8.22M +$384K +81,768 +6%
BlackRock
5
BlackRock
New York
$7.56M -$182K -38,776 -3%
JP Morgan Chase
6
JP Morgan Chase
New York
$5.14M -$676K -143,716 -13%
AMH
7
Apollo Management Holdings
New York
$3.55M
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.07M +$76.5K +16,280 +3%
State Street
9
State Street
Massachusetts
$2.35M +$16.4K +3,498 +0.8%
Jacobs Levy Equity Management
10
Jacobs Levy Equity Management
New Jersey
$1.99M +$360K +76,549 +25%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$1.98M -$143K -30,428 -8%
LFCM
12
Long Focus Capital Management
Puerto Rico
$1.58M +$1.41M +300,000 New
Millennium Management
13
Millennium Management
New York
$1.26M +$885K +188,147 +378%
PAM
14
Panagora Asset Management
Massachusetts
$1.25M +$836K +177,784 +300%
Charles Schwab
15
Charles Schwab
California
$1.17M +$112K +23,731 +12%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$1.07M +$45.6K +9,699 +5%
Northern Trust
17
Northern Trust
Illinois
$1.06M +$14.5K +3,080 +2%
Renaissance Technologies
18
Renaissance Technologies
New York
$922K +$457K +97,256 +126%
Morgan Stanley
19
Morgan Stanley
New York
$829K -$1.11M -236,907 -60%
BCM
20
Bridgeway Capital Management
Texas
$773K +$118K +25,000 +21%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$443K
Bank of New York Mellon
22
Bank of New York Mellon
New York
$317K -$29.5K -6,280 -9%
Squarepoint
23
Squarepoint
New York
$290K -$422K -89,695 -62%
CSS
24
Cubist Systematic Strategies
Connecticut
$241K +$209K +44,538 +4,128%
Mirae Asset Global Investments
25
Mirae Asset Global Investments
South Korea
$232K +$42.8K +9,106 +52%

SGHT Hedge Fund Activity: Q1 2024 in Review

65 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sight Sciences (SGHT) for Q1 2024, worth a combined $87.6M — up 0.43% from $87.2M a quarter earlier.

Fund positioning in SGHT was balanced in Q1 2024: 12 funds opened new positions, 12 closed out, 20 added to existing stakes and 23 trimmed.

The largest buyer was Long Focus Capital Management, opening a new position worth an estimated $1.41M. The largest seller was Morgan Stanley, cutting an estimated $1.11M.

  • 65 institutional investors held Sight Sciences (SGHT) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $87.6M of Sight Sciences stock for Q1 2024, up 0.43% quarter-over-quarter.
  • 12 funds opened new Sight Sciences positions in Q1 2024 and 12 closed out, a net change of 0 holders.
  • The largest Sight Sciences buyer in Q1 2024 was Long Focus Capital Management, an estimated $1.41M added.
  • The largest Sight Sciences seller in Q1 2024 was Morgan Stanley, an estimated $1.11M sold.

Based on aggregated 13F filings for Q1 2024.